Production

Aspen has 23 manufacturing facilities across 15 sites. One of our strategic thrusts is our manufacturing capability, and the sites we have in the group are not only known for quality and dependability but also are widely accredited, holding international approval from some of the most stringent global regulatory agencies. Our manufacturing capabilities spans a wide variety of product types including steriles, oral solid dose, liquids, semi-solids, biologicals and APIs. We have 7 API and 16 FDF manufacturing facilities worldwide. Our sites provide quality products whilst allowing for improved competitiveness and sustainability and they are pivotal to support our strategic manufacturing capacity requirements, to enable an affordable and secure supply of medicines and vaccines to markets across the world.